“Peg-Interferon Plus Ribavirin in Chronic Hepatitis C: Cost-Efficacy and Pharmacoutilization in Clinical Practice”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 9, no. 4, Jan. 2008, pp. 173-81, https://doi.org/10.7175/fe.v9i4.235.